Gap Junction Protein, alpha 8, 50kDa (GJA8) (Middle Region) Peptid
GJA8
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle GJA8 Produkte
- GJA8 (Gap Junction Protein, alpha 8, 50kDa (GJA8))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-GJA8 antibody (Catalog #: ARP36612_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- GJA8 (Gap Junction Protein, alpha 8, 50kDa (GJA8))
- Hintergrund
-
One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell. Defects in GJA8 are the cause of zonular pulverulent cataract type 1 (CZP1).
Alias Symbols: CAE, CAE1, CX50, CZP1, MP70
Protein Interaction Partner: MIP,TJP1,TJP1
Protein Size: 433 - Molekulargewicht
- 48 kDa
- Gen-ID
- 2703
- NCBI Accession
- NM_005267, NP_005258
- UniProt
- P48165
-
Sie sind hier:
